Novotech, is the largest full-service clinical CRO originating from Australia, with an extensive Asia Pacific footprint. Headquartered in Sydney, as of 2014 the company operates out of 12 countries in Australasia and South Africa, focusing on some of the fastest growing drug development markets in the world. Since commencing operations in 1996, Novotech has been the recipient of numerous national and international awards for its quality of service and is widely regarded as the premier small to midsize CRO servicing the needs of pharma and biotech drug developers in the Asia Pacific region.
